Whitehawk Therapeutics (WHWK) Preferred Dividend Payments (2016 - 2017)
Whitehawk Therapeutics (WHWK) posted quarterly Preferred Dividend Payments of $943297.0 for Q1 2017, down 7.1% year-over-year from $1.0 million in Q1 2016, and down 10.56% quarter-over-quarter from $1.1 million in Q4 2016.
Whitehawk Therapeutics (WHWK) Preferred Dividend Payments (2016 - 2017) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Preferred Dividend Payments for 2 consecutive years, with $943297.0 the latest figure, recorded in Q1 2017.
- In Q1 2017, Preferred Dividend Payments fell 7.1% year-over-year to $943297.0; the TTM figure through Dec 2017 stood at $943297.0 (down 77.29% YoY), while the FY2021 annual figure was $647000.0, changed N/A from the prior year.
- Preferred Dividend Payments retreated to $943297.0 in Q1 2017 per WHWK's latest filing, from $1.1 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $1.1 million in Q3 2016 and bottomed at $943297.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 943,297.00 |
| Dec 31, 2016 | 1.05 Mn |
| Sep 30, 2016 | 1.05 Mn |
| Jun 30, 2016 | 1.03 Mn |
| Mar 31, 2016 | 1.02 Mn |